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Abstract
Understanding the genetic, structural, and biophysical mechanisms that caused protein functions to evolve is a central goal
of molecular evolutionary studies. Ancestral sequence reconstruction (ASR) offers an experimental approach to these
questions. Here we use ASR to shed light on the earliest functions and evolution of the glucocorticoid receptor (GR), a
steroid-activated transcription factor that plays a key role in the regulation of vertebrate physiology. Prior work showed that
GR and its paralog, the mineralocorticoid receptor (MR), duplicated from a common ancestor roughly 450 million years ago;
the ancestral functions were largely conserved in the MR lineage, but the functions of GRs—reduced sensitivity to all
hormones and increased selectivity for glucocorticoids—are derived. Although the mechanisms for the evolution of
glucocorticoid specificity have been identified, how reduced sensitivity evolved has not yet been studied. Here we report on
the reconstruction of the deepest ancestor in the GR lineage (AncGR1) and demonstrate that GR’s reduced sensitivity
evolved before the acquisition of restricted hormone specificity, shortly after the GR–MR split. Using site-directed
mutagenesis, X-ray crystallography, and computational analyses of protein stability to recapitulate and determine the
effects of historical mutations, we show that AncGR1’s reduced ligand sensitivity evolved primarily due to three key
substitutions. Two large-effect mutations weakened hydrogen bonds and van der Waals interactions within the ancestral
protein, reducing its stability. The degenerative effect of these two mutations is extremely strong, but a third permissive
substitution, which has no apparent effect on function in the ancestral background and is likely to have occurred first,
buffered the effects of the destabilizing mutations. Taken together, our results highlight the potentially creative role of
substitutions that partially degrade protein structure and function and reinforce the importance of permissive mutations in
protein evolution.
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Introduction
A central goal in studies of molecular evolution is to reveal the
genetic, structural, and biophysical mechanisms by which protein
functions have evolved [1–6]. Ancient proteins and DNA are
seldom directly available, but the traces of their evolutionary
history are found in their extant descendants [7]. Direct
comparisons among present-day proteins can sometime yield
insights into the sequence and structural mechanisms that underlie
functional differences [8–11]. Such ‘‘horizontal’’ comparisons,
however, cannot determine which protein features are ancestral
and which are derived, so they are not suited to reconstructing the
events that produced functional diversity [12]. Further, because
the effect of a mutation on protein structure and function often
depends on the residues present at other sequence sites [13–17],
studies of extant proteins may often be unsuited to revealing the
effects of mutations in the historical backgrounds in which they
occurred [12].
Ancestral sequence reconstruction (ASR) allows the forms and
functions of ancient proteins to be studied experimentally.
Beginning with an alignment of extant sequences, the maximum
likelihood phylogeny and best-fit probabilistic model of evolution
are inferred; the most likely ancestral sequence at any node –
defined as the sequence with the highest probability of delivering
all the observed extant sequences – can then be identified [18].
These ancestral protein sequences can be ‘‘resurrected’’ using gene
synthesis and cell culture or in vitro expression systems and then
characterized using the same methods typically applied to study
extant proteins. This approach allows hypotheses about the
ancestral and derived characteristics of proteins to be tested
experimentally. It also allows the historical interval during which
structure and function changed to be identified and the causal role
of specific historical mutations in the ancestral background to be
determined.
The glucocorticoid and mineralocorticoid receptors (GR and
MR) are paralogous hormone-regulated transcription factors that
have served as useful models for studying protein evolution
[15,16,19]. GR and MR have a modular domain structure that
includes a well-conserved DNA-binding domain (DBD) and a
moderately conserved ligand-binding domain (LBD) – which binds
the hormone, changes conformation, and attracts coactivator
proteins that potentiate transcription of nearby target genes; they
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most bony vertebrates, the intrinsic functions of the GR and MR
LBDs differ in both specificity and sensitivity. GR is more specific,
being activated by high doses of the adrenal hormone cortisol to
regulate aspects of immunity, glucose metabolism, and the long-
term stress response [20,21]. MR, in contrast, is activated by the
adrenal mineralocorticoids aldosterone or deoxycorticosterone, as
well as cortisol (albeit with somewhat lower sensitivity), and
primarily regulates osmotic homeostasis. GR is also considerably
less sensitive than MR, often requiring concentrations several
orders of magnitude higher for activation [19,22,23].
Some information is available on GR and MR evolution. The
two paralogs descend by duplication from a single ancestral
corticosteroid receptor (AncCR), which existed in an ancient
jawed vertebrate ,450 million years ago, before the divergence of
bony vertebrates from cartilaginous fishes (Figure 1) [19,24].
Reconstruction and experimental analysis showed that AncCR,
like the extant MRs, was extremely sensitive to both mineralo-
corticoids and glucocorticoids, and its structure was MR-like, as
well [19]. Subsequent work revealed that GR’s specificity for
glucocorticoids evolved later in the lineage leading to bony
vertebrates, after the divergence of cartilaginous fishes but before
the split of ray-finned fish from the lineage leading to tetrapods
and lobe-finned fish, due to a small specific set of historical
mutations [15,16,19] (Figure 1).
The evolutionary causes of GR’s reduced hormone sensitivity
are not known. In the little skate – the only cartilaginous fish
studied to date – GR is a low-sensitivity, broad-spectrum receptor:
like MR, it responds to both glucocorticoids and mineralocorti-
coids, but it is unique in requiring high concentrations of either
type of hormone to activate it. The difference in receptor
sensitivity between the GR and MR is thought to have
physiological consequences: in several elasmobranch species, the
same corticosteroids appear to regulate both stress and osmolarity
[25–28], and the highest titres are associated with stress conditions
[29,30]. These observations suggest that GR regulates stress in
response to high doses of hormones, while MR regulates
osmolarity in response to much lower doses [23].
Based on these data, we hypothesize that GRs’ reduced
sensitivity to all hormones was an independent evolutionary event
that occurred before cartilaginous fishes split from bony
vertebrates, and before glucocorticoid specificity evolved in the
GRs of bony vertebrates [15,19]. Here we report on experiments
to test this hypothesis and determine the genetic, structural, and
biophysical mechanisms by which GR’s reduced hormone
sensitivity evolved. We first resurrected the LBD of AncGR1
(Figure 1) – the GR protein present in the common ancestor of
bony and cartilaginous vertebrates and the earliest node after the
GR-MR split – and then used functional assays, X-ray
crystallography, site-directed mutagenesis, and computational
predictions of biophysical parameters to dissect the mechanisms
by which GR evolved. We show that after its initial birth by gene
duplication, a small number of mutations that partially degraded
its structure, stability, and function caused GR to become a novel
low-sensitivity receptor.
Results
Isolation and Characterization of Cartilaginous Fish GRs
Statistical confidence in ASR depends in part on taxon sampling
in groups descending directly from the node of interest [31–33].
Although GR sequences are available from many bony verte-
brates, only a single GR sequence from cartilaginous fishes has
been previously sequenced. We therefore isolated additional GRs
sampled from throughout the cartilaginous fishes and character-
ized the functions of their LBDs. Specifically, we isolated GRs
from four elasmobranch species – the Atlantic sharpnose shark
(Rhizoprionodon terraenovae), brownbanded bambooshark (Chiloscyl-
lium punctatum), small-spotted catshark (Scyliorhinus canicula), and the
Atlantic stingray (Dasyatis sabina) – and one holocephalan, the
elephant shark (Callorhincus milii) (Figure 1).
We used a luciferase reporter gene expression assay to
characterize the sensitivity of each LBD to four major corticoste-
roids present in elasmobranchs – 11-deoxycorticosterone (DOC),
corticosterone, 1alpha-hydroxycorticosterone, and 11-dehydrocor-
ticosterone [34,35]. All elasmobranch GRs were low-sensitivity
receptors activated by multiple corticosteroids, except for the D.
Sabina GR, which did not activate transcription in the presence of
any hormone. All hormone-activated cartilaginous fish GRs were
most sensitive to DOC and corticosterone. The receptors had
EC50 values (the hormone concentration required to elicit half-
maximal activation) for these steroids in the 10
28 to 10
26 M range
(Figure 2, Table S1), typical of the EC50s of bony fish GRs for
glucocorticoids but two to four orders of magnitude greater than
AncCR or the MRs of bony vertebrates [19]. These observations
are consistent with a model that after duplication of AncCR –
which was highly sensitive to a broad array of corticoisteroids –
GR evolved reduced sensitivity without a shift in specificity,
explaining the observed characteristics of AncGR1 and the GRs of
extant elasmobranchs; later – after elasmobranchs diverged from
bony vertebrates – the narrower specificity for glucocorticoids that
characterizes the GRs of present-day tetrapods and teleosts
evolved (Figure 1).
Reconstruction and Functional Analysis of the Ancestral
GR
The new cartilaginous fish GR sequences were added to a
dataset of 97 other steroid receptor sequences and aligned for
phylogenetic analyses and ancestral sequence reconstruction. The
maximum likelihood phylogeny was generally well supported and
Author Summary
A central question in molecular evolution is how changes
in the genetic, structural, and biophysical properties of
proteins generate new functions. Ancestral sequence
reconstruction (ASR) allows long-extinct proteins to be
resurrected and characterized in the laboratory and allows
the mechanisms for evolutionary shifts in protein functions
to be studied experimentally. We used ASR to study the
earliest functions and evolution of the glucocorticoid
receptor (GR), a hormone-activated transcription factor
and critical regulator of vertebrate physiology. We
reconstructed the first GR ancestor and showed that this
ancient gene evolved dramatically reduced sensitivity to
hormone shortly after its birth by gene duplication some
450 million years ago, a function that persists in GRs to this
day. Using site-directed mutagenesis, X-ray crystallogra-
phy, and computational predictions of protein stability, we
found that the shift to reduced GR sensitivity was driven
by two large-effect mutations that destabilized the
receptor-hormone complex. The combined effect of these
mutations is so strong that a third mutation, apparently
neutral in the ancestral background, evolved to buffer
their degenerative effects. Our results suggest a creative
role for mutations that partially degrade protein form and
function and highlight the importance of interactions
between mutations in evolutionary processes and protein
functions.
Evolution of the Ancestral Glucocorticoid Receptor
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placement of the agnathan receptors (Figure S1, Table S2).
The hypothesis that GR’s functions are derived can be tested
experimentally and by sequence analysis of evolutionary rates.
This hypothesis predicts that the rate of amino acid evolution after
duplication of AncCR should be faster in the lineage leading to the
GRs than in that leading to the MRs, which retain the ancestral
functions [3]. Branch lengths between two nodes represent the
mean probability of substitution per site, which equals the product
of evolutionary rate times time. The branch leading from AncCR
to AncGR1 and the branch leading from AncCR to AncMR1
(MR in the same ancestral species—the common ancestor of
jawed vertebrates) cover exactly the same period of time, so any
authentic differences in length must be due to differences in
evolutionary rate. As predicted, there are 36 differences between
the AncCR and AncGR1.1, compared to 16 between AncCR and
AncMR1, and the estimated amino acid replacement rate 2.25
times greater on the GR branch than on the MR branch (Figure 1),
but this difference did not reach formal statistical significance
(p=0.09) using a likelihood ratio test.
TomoredecisivelytestthehypothesisthatGR’sfunctionschanged
between AncCR and AncGR1, we used ancestral reconstruction. We
inferred the sequence of AncGR1 assuming the best-fit model and
integrating over plausible phylogenies weighted by their posterior
probabilities [36]. The denser taxon sampling of this study was found
to improve confidence in the inferred AncGR1 sequence compared
to the previously published version, which was inferred from an
alignment that included only a single cartilaginous fish [15]. The
updated reconstruction, which we named AncGR1.1, differs at 7% of
sites from the original reconstruction (AncGR1.0), with a higher
mean posterior probability across all sites (0.951 vs. 0.930), a greater
number of sites reconstructed with 100% posterior probability, and
fewer sites reconstructed with plausible alternate states (Figure S2,
Table S3). Other previously reconstructed ancestral steroid receptor
sequences, such as AncCR and AncGR2 (the GR gene in the last
common ancestor of ray- and lobe-finned fishes, including tetrapods)
[19], were affected to a much lesser extent by including additional
cartilaginous fish sequences.
We then characterized the functions of the AncGR1.1 LBD by
synthesizing a nucleic acid sequence that codes for it, subcloning
that sequence into an expression construct, and assaying its
sensitivity to the same suite of corticosteroids using the luciferase
reporter assay. As predicted, we found that AncGR1.1 is activated
by the same broad suite of hormones as AncCR, but markedly
higher doses are required. For all ligands tested – including the
classicmineralocorticoid DOC– AncGR1.1was25-to 530-fold less
responsive to hormone than AncCR (Figure 2, Table S1). These
data allow us to trace on the phylogeny two separate shifts in the
evolutionof GRs from a high-sensitivity, promiscuous corticosteroid
receptor: first, the evolution of reduced hormone sensitivity, and
later a loss of sensitivity to mineralocorticoids (Figure 1).
To determine whether AncGR1.19s reduced sensitivity could be
an artifact of uncertainty in the ancestral sequence reconstruction,
we introduced plausible alternate states into the maximum
likelihood ancestral sequence and repeated the experimental
characterization. None of these contradicted the finding that
Figure 1. Simplified phylogeny of corticosteroid receptors. Ancestral sequences are shown at relevant nodes: AncCR, the last common
ancestor of all MRs and GRs; AncGR1, the GR ancestor of cartilaginous fishes and bony vertebrates; AncGR2, the GR ancestor of ray- and lobe-finned
fishes (including tetrapods); AncMR1, the MR ancestor of cartilaginous fishes and bony vertebrates. (AncGR1.0 and AncGR1.1 are different
reconstructions of node AncGR1, inferred from datasets with different taxon sampling.) Black, high sensitivity receptors; gray, low sensitivity
receptors. Single and double gray dashes mark functional shifts towards reduced sensitivity and increased specificity, respectively. Support values are
the chi-square statistic (1 – p, where p equals the estimated probability that a node could occur by chance alone) calculated from approximate
likelihood ratios. The length of branches from AncCR to AncMR1 and to AncGR1, expressed as the mean number of substitutions per site, are
indicated in parentheses.
doi:10.1371/journal.pgen.1002117.g001
Evolution of the Ancestral Glucocorticoid Receptor
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to AncCR (Table S1). Taken together, these observations indicate
that reduced sensitivity evolved in the GR lineage after duplication
of AncCR but before the split of cartilaginous from bony
vertebrates, and this conclusion is robust to uncertainty about
the ancestral reconstruction.
Genetic Basis of Reduced AncGR1.1 Sensitivity
We next sought to identify the genetic mechanisms that caused
reduced hormone sensitivity to evolve. Because the shift in
function occurred on the branch between AncCR and AncGR1.1,
the initial set of candidate mutations includes the 36 historical
substitutions that occurred on this same branch. At 17 of these
sites, the same derived state is present in both AncGR1.1 and
AncGR1.0: AncGR1.0 is much more similar in sensitivity to
AncCR than AncGR1.1 is (Figure 2), so substitutions at these sites
are unlikely to represent the major-effect mutations. Of the 19
substitutions that are unique to AncGR1.1, twelve represent
biochemically conservative replacements (e.g., D/E, I/L, K/R, S/
T). Only one of the others is in a position predicted to contact
ligand based on the crystal structures of other steroid receptors
[15,37]; this substitution (A36G) was previously tested in AncCR
and found to have no significant effect on sensitivity to DOC or
other corticosteroids [19]. We therefore prioritized the six
remaining biochemically radical replacements as the best candi-
dates for having caused the evolution of reduced sensitivity.
We introduced each candidate mutation into the maximum
likelihood (ML) AncCR background using site-directed mutagenesis
and tested its effect on hormone sensitivity in the luciferase reporter
gene assay with increasing concentrations of DOC. Two substitu-
tions – V43A and R116H – markedly reduced AncCR’s sensitivity
to hormone, increasing the receptor’s EC50 of DOC by at least two
orders of magnitude to AncGR1.1-like values (Figure 3, Table 1).
The others had much weaker effects on sensitivity. The double
mutant V43A/R116H was severely compromised, with an EC50 for
DOC ,10,000 times greater than AncCR and more than 50 times
greater than even AncGR1.1. These results indicate that V43A and
R116H are large-effect historical mutations that are more than
sufficient to recapitulate the evolution of the low-sensitivity
AncGR1.1. They also indicate that the effects of these two
mutations on receptor sensitivity must have been partially buffered
by additional substitutions that occurred during the same interval.
Crystal Structure of the AncGR1:DOC Complex
To understand the structural basis of reduced GR sensitivity
and identify other important substitutions, we purified AncGR1.1
expressed in E. coli and used X-ray crystallography to determine its
atomic structure in complex with DOC at 1.95 A ˚ resolution (see
Table S4). AncGR1.1 adopts the classic steroid receptor active
conformation [38], consisting of three helical layers, an internal
ligand cavity bounded by helices 3, 5, 6, 7, and 10, well-defined
ligand density within the cavity, and a surface for coactivator
binding formed by helices H3, H5, and H12 [39].
The conformation of AncGR1.1 is very similar to the previously
determined AncCR crystal structure, with a root mean square
deviation (RMSD) in backbone atom position of only 0.66 A ˚
(Figure 4A), and most of the larger deviations are far from the
ligand. The side chain identity of all residues within 4 A ˚ of DOC
are conserved except for A36G, which alters a ligand-contacting
residue but has no discernible effect on hormone sensitivity [19].
These results indicate that AncGR1.19s reduced sensitivity to
hormone must be due to indirect mechanisms not involving
contacts with the ligand, such as changes to intraprotein contacts
that affect the stability of the protein-hormone complex.
Desensitizing Mutations Caused a Loss of Intra-Protein
Interactions
To understand the mechanisms by which mutations V43A and
R116H reduced hormone sensitivity, we first examined the
Figure 2. AncGR1 and its descendents evolved reduced
hormone sensitivity. Ligand-dependent transcriptional activation of
receptors was measured in the presence of increasing concentrations of
hormone using a luciferase reporter gene assay. Dose-response curves
were calculated for receptor-hormone pairs and plotted as the log
effective concentration of hormone for half maximal activation (log
EC50) in molar with standard error. Larger values, lower sensitivity;
smaller values, higher sensitivity. Hormones are: 11-deoxycorticoste-
rone (DOC), corticosterone (B), 11-dehydrocorticosterone (11-DHC), and
1a-hydroxycorticosterone (1a-B). Cartilaginous fish species are shown in
(Figure 1). 11-DHC did not activate cartilaginous fish GRs in our assay
(defined as ,2-fold activation for EC50.1 mM of hormone) and is not
shown for these receptors.
doi:10.1371/journal.pgen.1002117.g002
Figure 3. Three historical substitutions in AncCR recapitulate
the evolution of reduced sensitivity. Shown is the log EC50 of
molar DOC with the highly sensitive ancestor (AncCR, gray), the low
sensitivity descendent (AncGR1.1, yellow), and AncCR mutants. Single
and combination mutants are denoted with colored asterisks: V43A,
pink; R116H, blue; C71S, orange.
doi:10.1371/journal.pgen.1002117.g003
Evolution of the Ancestral Glucocorticoid Receptor
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crystal structures. Position 43 faces inward on the middle of H3,
just above the ligand where H3 packs against H5 and forms part of
the coactivator-binding cleft. In AncCR, Val43 packs tightly
against neighboring hydrophobic residues, making van der Waals
contacts with Leu72, presumably stabilizing H3 and H5, which
participate in forming both the coactivator interface and the ligand
pocket (Figure 4B). In AncGR1.1, the smaller side chain of Ala43
loses its van der Waals contacts to Leu72, opening a small cavity in
this region (Figure 4C). The poor packing that results is expected
to destabilize the receptor-ligand complex.
Position 116 is situated on H7, the opposite side of the protein
from site 43. In AncCR, R116 is a hub in a network of hydrogen
bonds between H7 and residues in H5 and H6 (Figure 4D). In
AncGR1.1, this hydrogen-bond network is much sparser, largely
due to the replacement of Arg116 with His (Figure 4E). The loss of
favorable interactions presumably destabilizes these helices, the
ligand pocket, and possibly the coactivator interface.
We also noted that a third historical substitution in this
region, Q113K, abolishes other hydrogen bonds in the same
network as Arg116H. When we introduced Q113K into
AncCR, it also reduced sensitivity, though its effect was
considerably smaller than those of V43A and R116H
(Table 1). The loss of favorable interactions in the atomic
structure due to substitutions at sites 43, 116 and 113, together
with the experimental finding that these mutations recapitulate
the evolutionary decline in AncCR’s hormone sensitivity,
suggests that AncGR1’s novel function – its reduced sensitivity
to corticosteroids – evolved because of the partial degeneration
of ancestral structures and functions.
C71S Buffers against Desensitizing Mutations
Because introducing mutations V43 and R116H together into
AncCR reduces sensitivity to an extent greater than the
historical difference between AncCR and AncGR1, other
historical substitutions during the same interval must have
buffered the impact of these large-effect mutations. Of the
remaining candidate mutations, one – C71S – occurred at a site
already known to have a strong positive effect on receptor
function in extant steroid hormone receptors: introducing serine
at the homologous site in mammalian GRs (F602S) dramatically
improves bacterial expression, solubility, and crystallization
[15,16,37,40–2]. To test the hypothesis that the historical
acquisition of Ser71 buffered the effect of mutations at sites 43
and 116, we introduced mutation C71S into AncCR-V43A/
R116H background. As predicted, this additional change
improved sensitivity by ,90-fold, yielding a receptor with
DOC sensitivity similar to that of AncGR1.1. In isolation,
however, the C71S substitution has no discernable effect on
AncCR sensitivity (Figure 3, Table 1).
The biophysical mechanism for this buffering effect is not
clear. All previously crystallized corticosteroid receptors, ancestral
and extant, have had Ser71 engineered into them to aid in
protein expression and crystallization [15,16,37,40–2]; compar-
ison to receptor agonist structures lacking Ser71 is therefore not
possible. In both the AncCR and AncGR1.1 structures, this site is
located on H 5 in the central core of the protein, just above the
ligand-binding pocket, bordering a distinctive kink in H5
(Figure 5). Ser71 is adjacent to a highly solvated channel next
to the hydrophobic core of the receptor, and a serine substitution
would increase the hydrophilicity of the region compared to the
ancestral cysteine. It appears that Ser71 in Chain B of AncGR1.1
might stabilize the receptor through direct and water-mediated
hydrogen bonds that a cysteine would not form (Figure 5). This is
not a strictly conserved mechanism, however, because in the
structures of AncCR-C71S (Figure 5, inset) and Chain A of
AncGR1.1, the polar Ser71 side chain occupies an alternate
conformation: it interacts with water molecules in the channel,
but the bond network varies among the structures. An alternate
explanation for the buffering effect of C71S is that it may
facilitate proper folding and solubility of the protein, an effect
that could have a more beneficial effect on receptors with less
stable native conformations, such as those carrying the V43A or
R116H substitutions.
Desensitizing Mutations Are Predicted to Be
Thermodynamically Destabilizing
To test the hypothesis that the evolutionary reduction in GR
sensitivity was due to mutations that destabilized the receptor-
hormone complex, we used a computational approach to
predict the effects of historical GR mutations on the stability
of AncCR. Using the AncCR:DOC crystal structure as a
starting-point, we used FoldX software [43] to generate single
and combination AncCR mutants, optimize the predicted
structures, and calculate the predicted change in free energy
of folding (DDG) for mutant receptors. We calculated the
distribution of stability effects for 29 single-substitution mutants
and found that V43A and R116H are, as predicted, the most
destabilizing substitutions, reducing stability by 1.62 and
2.81 kcal/mol, respectively (Figure 6A, Table S5). The buffer-
ing mutation C71S had a very weakly destabilizing effect
(0.29 kcal/mol). The combination V43A/R116H is predicted to
be extremely destabilizing in AncCR (5.31 kcal/mol); addition
of C71S to this background causes a slight additional decrease
in stability (5.41 kcal/mol).
We found a strong overall correlation between the predicted
effects of mutations on protein stability and the observed reduction
in receptor sensitivity to hormone (r
2=0.78; Figure 6B, Table 1,
Table S5). The relationship is even tighter (r
2=0.89) when C71S-
Table 1. Response of ancestral and mutant receptors to 11-
deoxycorticosterone (DOC).
Receptor
a log EC50
b SE Fold change in EC50
c
AncCR 210.870 0.34 -
AncGR1.1 28.144 0.20 532.1
C71S 210.690 0.64 1.5
A107S 210.350 0.24 3.3
K83Q 210.330 0.41 3.5
L1M 210.250 0.30 4.2
Q211E 210.170 0.43 5.0
Q113K 29.773 0.43 12.5
R116H 28.812 0.28 114.3
V43A 28.443 0.15 267.3
43/71/116 28.387 0.54 304.1
43/116 26.418 0.06 28313.9
aAll mutations were introduced into the AncCR background; AncGR1.1 is shown
for comparison. Mutations are listed in order of the magnitude of their effect.
bThe log effective concentration of hormone for half-maximal activation plus
standard error, calculated from nonlinear regression of triplicate reactions in a
reporter gene assay.
cFold change in EC50 indicates the ratio of EC50 of the listed receptor to the EC50
of AncCR, both for deoxycorticosterone. Positive values indicate reduced
sensitivity.
doi:10.1371/journal.pgen.1002117.t001
Evolution of the Ancestral Glucocorticoid Receptor
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hypothesis that V43A, R116H, and Q113K caused the evolution
of reduced receptor sensitivity by destabilizing the protein-
hormone complex, while C71S partially buffered the effects of
these mutations through mechanisms not directly related to
protein stability.
Discussion
Our analyses allow a detailed description of the genetic,
structural, and biophysical mechanisms by which AncGR1
evolved its derived function – sensitivity to only high concentra-
tions of corticosteroid hormone – after duplication of an ancestral
Figure 4. The crystal structure of AncGR1.1-LBD in complex with DOC (yellow, PDB 3RY9) compared to the previously solved
structure of AncCR with DOC (gray, PDB 2Q3Y). Green sticks indicate DOC; possible hydrogen bonding indicated by red dashes. Helices are
indicated by light grey text; AF-H equals H12, the activation function helix. A) AncCR and AncGR1.1 are highly structurally conserved despite 36
substitutions between them. Spheres show sequence differences: pink, position 43; blue, position 116; orange, position 71. B) and C) show the
structural environment around position 43. The substitution of V43 in AncCR (B) in place of A43 in AncGR1.1 (C) is thought to weaken the
hydrophobic interactions of the surrounding helices. D) and E) show the structural neighborhood of position 116. Replacing R116 (D) with H116 (E),
along with a Q113K substitution, significantly reduces and rearranges ancestral hydrogen bonding.
doi:10.1371/journal.pgen.1002117.g004
Evolution of the Ancestral Glucocorticoid Receptor
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The shift appears to have been driven primarily by two large-effect
mutations that caused partial degradation of the receptor’s
structure and function. The mechanism for the functional change
appears to be that these mutations compromised favorable
hydrophobic interactions and hydrogen bonds in the ancestral
protein, destabilizing the hormone-receptor complex. Although
the combined effect of the two large-effect mutations is so great
that they nearly abolish hormone sensitivity in the double mutant,
a third mutation – which occurred during the same historical
interval strongly buffers their effect. This buffering mutation
causes no apparent effect on function in isolation; we therefore
conjecture that this mutation occurred as a permissive mutation
before V43A and R116H were established. Additional substitu-
tions subsequently tuned the sensitivity of AncGR1 and its
descendants. Our results do not allow us to determine the roles
of selective and neutral processes in the fixation of these mutations,
and the physiological significance of the GR’s reduced sensitivity
in the ancestral organism is unknown; it is possible, however, that
the advent of a low-sensitivity GR, along with the high-sensitivity
MR, allowed a greater degree of endocrine control by different
doses of corticosteroids, as appears to be the case in extant
elasmobranchs.
Modulating the stability of a protein:ligand complex represents
one way to alter the effective dose of ligand required to produce
some specific quantity of active complex. During the evolution of
AncGR1, this outcome was achieved through mutations that
disrupted favorable contacts among structural elements of the
peptide itself, without directly affecting receptor-ligand contacts.
Our findings add to a growing literature on the evolution of
protein stability. Random mutations are more likely to reduce
than increase protein stability [44–46]. Periods of mutation
accumulation without purifying selection can quickly degrade
proteins structures so they fall below the minimum threshold for
folding and activity [13,14,47,48]. Although most proteins are
marginally stable, a protein’s precise distance from this threshold is
dynamic, depending on the specific balance of stabilizing and
destabilizing mutations that have occurred [13,49]. A stability
threshold can also be relaxed by mechanisms such as the
overexpression of chaperone proteins [50] or decreased selection
for optimal protein function [14]. ‘‘Global suppressor’’ mutations
that increase protein stability allow a greater number of
destabilizing mutations to accumulate than would otherwise be
Figure 5. The structural context of site 71. S71 (orange) in
AncGR1.1 (Chain B, yellow) forms a water-mediated hydrogen bond
with the carbonyl carbon of L139 and the T143 side chain. In AncCR, the
side chain of an engineered S71 mutant adopts a slightly different
conformation (inset). The C71S substitution increases the hydrophilicity
of the region. Also shown are the relative locations of the ligand, DOC
(green); V43A (pink); the R116H and Q113K substitutions (blue); possible
hydrogen bonding (red dashes); and relevant helices (light grey text).
doi:10.1371/journal.pgen.1002117.g005
Figure 6. The effect of historical GR substitutions on AncCR protein stability, predicted by FoldX [43]. A) The distribution of stability
effects (DDG) for almost all (n=29 of 36) single GR substitutions in the AncCR background. Colored asterisks indicate bins with notable mutants:
V43A (pink), R116H (blue), and C71S (orange). B) For those mutants in which hormone sensitivity was assessed (n=10, plus AncCR), the predicted loss
of stability correlates well with the observed loss of sensitivity towards DOC. Linear regression with C71S mutants, r
2=0.78; without, r
2=0.89. Single
and combination mutants are colored as in (A). X values are the average of five FoldX runs with standard deviation; Y values are the mean of triplicate
reactions with standard error. The intercept lies at values for AncCR (0, 210.870).
doi:10.1371/journal.pgen.1002117.g006
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[15,17,49,51,54–56].
Our observations indicate that destabilizing mutations can be
buffered not only by permissive mutations that increase stability
but also by those that affect protein structure and function via
other biophysical mechanisms, such as folding or solubility
[57,58]. The extreme reduction in stability conferred on
AncGR1.1 by mutations at sites 43 and 116 are strongly buffered
by historical mutation C71S, which does not affect function in
isolation and is not predicted to alter protein stability. Previous
studies in extant proteins have shown that introduction of a serine
at the homologous site in rat and human GRs increases
transcriptional activity and ligand affinity [59] and dramatically
improves protein solubility and expression in bacterial cells
[15,16,37,40–42]. It has been proposed that the serine maintains
the receptor in an ‘‘agonist-like’’ conformation, preventing the
collapse and aggregation of the LBD [60]. Effects on protein
folding and aggregation may explain why C71S by itself is neutral
in AncCR and yet, in the context of strongly destabilizing
mutations, is required to maintain the active conformation and
function. An alternative explanation is that C71S may play a local
role in maintaining secondary structural elements and the spatial
relations between them in the active conformation; the location of
C71S on H5, directly opposite where V43A packs against H5,
lends credence to this possibility. Additional experiments will be
necessary to directly measure the effects of mutations at sites 43,
71, and 116 on the protein’s biophysical properties.
Our study highlights a creative role for partial loss-of-function
mutations in the evolution of novel genes and gene functions. This
aspect of GR evolution is related to the process described by
Bridgham et al. [61] during post-duplication evolution of a
different steroid receptor: in that case, a loss-of-function mutation
abolished the modular LBD’s ligand-activated transcriptional
function and generated a competitive repressor that retained its
ability to compete with its paralog for DNA and dimerization
partners. The mechanism we observed during AncGR1 evolution,
in contrast, involved a partial loss of activity, leading to
densensitization of the receptor and a novel response to existing
hormone levels. Steroid signaling relies on very precise molecular
cues, and changes in receptor sensitivity can have noticeable
effects on biological response [62]. After duplication of AncCR,
MRs retained the ancestral receptor’s sensitivity, while the
evolution of reduced sensitivity in the GR created a distinctly
different transcriptional regulator that responded only to high
doses of hormone. These observations demonstrate how mutations
that abolish or impair native protein functions can drive the
evolution of novel functional roles after gene duplication [3].
Methods
Receptor Isolation
The little skate (Leucoraja erinacea) GR ligand-binding domain
(LBD) was isolated previously using degenerate PCR and RACE
with liver cDNA [19]. The skate GR protein sequence was used in a
tblastn search of the elephant shark genome (http://esharkgenome.
imcb.a-star.edu.sg/) to identify its GR LBD, and gene-specific
primers were designed to amplify the coding sequence from cDNA.
All other cartilaginous fish GR LBDs were isolated by hemi-
degenerate PCR from cDNA using a degenerate primer in the GR
DNA-binding domain (DBD) in combination with a gene-specific
primer for a ,25 bp sequence conserved in the 39-UTR of the
elephant shark and skate (59-TCATATGCACTACATATGGTT-
TACAGA-39). In total, GR LBDs were amplified using high-fidelity
PCR from five cartilaginous fish species: elephant shark (Callorhincus
milii), Atlantic sharpnose shark (Rhizoprionodon terraenovae), brown-
banded bambooshark (Chiloscyllium punctatum), small-spotted cat-
shark (Scyliorhinus canicula), and Atlantic stingray (Dasyatis sabina).
Template cDNA for PCR was graciously provided by B. Venkatesh
(C. milii and C. punctatum) and B.S. Nunez (R. terraenovae, S. canicula,
and D. sabina).
Phylogenetic Analysis
The conserved DNA- and/or ligand-binding domains of 97
steroid receptor protein sequences were aligned using Clustal X
[63]. Maximum likelihood phylogenetics was performed using
PhyML_aLRT [64] assuming the Jones model of evolution [65]
and a four-category discrete gamma distribution of among-site rate
variation, with the shape parameter estimated from the data; the
JTT model was previously shown to be highly supported, with
100% posterior probability, when this and other models are
compared in a Bayesian analysis [19]. Support at nodes was
calculated as the chi-square statistic using an approximate
likelihood ratio test [64]; the chi-square statistic represents 1-p,
where p is the estimated probability that the given node would
occur by chance alone.
Ancestral Sequence Reconstruction and Gene
Resurrection
The maximum likelihood tree topology differed from previously
published SR phylogenies with respect to the placement of jawless
fish receptors [19]; to account for this uncertainty, ancestral
receptor sequences were reconstructed over both the experimental
and published trees weighted by their inferred posterior probabil-
ity [36]. Ancestral states were inferred using PAML version 3.15
[66] and the ancestral reconstruction tool Lazarus [36], given the
sequence alignment, phylogenies, and the JTT model. For any
ancestor relevant to our study, no site in the inferred sequence
possessed amino acid states that differed between trees. A nucleic
acid sequence coding for the LBD of the last common ancestor of
all GRs (AncGR1.1) was optimized for expression in mammalian
cells, synthesized de novo (Genscript, Piscataway, NJ), and
characterized as described below.
Tests of Evolutionary Rates
Rates of protein evolution were analyzed in HyPhy [67]. A
likelihood ratio test (LRT) was used to compare the relative branch
lengths from the last common GR/MR ancestor (AncCR) to the
last common ancestors of all GRs (AncGR1.1) or MRs (AncMR1).
Under the null hypothesis of equal rates, all branch lengths were
unconstrained and optimized independently; under the alternate
hypotheses, the branch leading from AncCR to AncGR1 was
constrained to have the same length as that leading from AncCR
to MR1 (MR in the ancestor of all jawed vertebrates). The
likelihood ratio of alternate and null models was determined and a
p-value calculated using a chi-squared distribution with one degree
of freedom.
Receptor Characterization
LBDs were cloned as fusion proteins into a pSG5-Gal4DBD
expression vector (gift of D. Furlow) and cotransfected using
Lipofectamine and Plus Reagents (Invitrogen, Carlsbad, CA) with
a UAS-driven luciferase reporter gene (pFRluc) into mammalian
cell culture (CHO-K1), and grown in phenol red-free a-MEM plus
10% dextran-charcoal-stripped fetal bovine serum (Hyclone,
Logan, UT). Cells were incubated with transfection reagents for
four hours, after which they were treated with fresh medium; after
recovery, cells were treated in triplicate with hormone or vehicle
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measured using Dual-Glo (Promega, Madison, WI) and dose-
response relationships analyzed using Prism4 (GraphPad, La Jolla,
CA). Site-directed mutagenesis was carried out using Quick-
Change II (Stratagene, La Jolla, CA) and clones verified by DNA
sequencing. Plausible alternate states were defined as non-
maximum likelihood amino acid states with posterior probability
.0.20; we reasoned that residues that are present in one or more
extant high-sensitivity receptors are the most likely to increase
receptor sensitivity, whereas those that are present only in low-
sensitivity receptors are unlikely to confer high sensitivity. Each
such alternate state was introduced singly into the ML AncGR1.1,
and the experimental characterization was repeated.
Protein Growth, Purification, and X-Ray Crystallography
AncGR1.1 was subcloned into the pMCSG7-MBP-His expres-
sion vector, transformed into BL21 (DE3) pLysS cells, and grown to
an OD600 of 0.8–1.0. Cultures were induced with 0.1 mM IPTG
plus 50 mM of the steroid 11-deoxycorticosterone (DOC) and
grown overnight at 16uC. Purification of AncGR1.1 was performed
using nickel affinity chromatography and a sizing column. Pure
AncGR1.1 was concentrated to 3.7 mg/mL and dialyzed into a
crystallization buffer consisting of 20 mM Tris, pH 6.5, 150 mM
NaCl, 5% glycerol, 50 mM CHAPS, and 50 mM hormone (DOC).
Multiple sparse matrix screens were set with AncGR1.1 protein
using a Phoenix crystallization robot (Art Robbins Instruments,
Sunnyvale, CA); hits formed at 22uC from the Salt Rx screen
(Hampton Research, Aliso Viejo, CA). Crystals were optimized at
22uC in hanging drop diffusion plates with: 2.5–2.8 M sodium
acetate trihydrate, pH 7.0, 0.1 M BIS-TRIS propane, pH 7.0, and
a small peptide designed from the TIF2 Box3 steroid receptor
coactivator protein. Crystals were soaked in a cryoprotectant
solutioncontaining20%glycerolandflash-frozeninliquid nitrogen.
Data was collected to 1.95 A ˚ resolution at the South East Regional
Collaborative Access Team (SER-CAT) at the Advanced Photon
Source (Argonne National Laboratory) and data was processed and
scaled with HKL2000 [68]. Initial phasing of the AncGR1.1 plus
DOC structure was determined using molecular replacement of the
AncCR with DOC (2Q3Y); model building and refinement of the
structure was carried out using COOT version 0.5 [69] and
REFMAC [70] in the CCP4 suite [71]. The root mean square
deviation (RMSD), a measure of the overall similarity between
protein backbones, was calculated using CaspR [72]. Interpretation
was focused on Chain B, which displayed lower overall b-factors
and had fewer crystal-packing contacts. Coordinates have been
deposited in PDB with accession 3RY9.
Analyses of Protein Stability
We used FoldX version 3.0 Beta 4 [43] to predict protein
stability of AncCR and its mutational variants, using the empirical
AncCR structure (PDB 2Q3Y, which contains an engineered
C71S mutation to facilitate expression and crystallization) as a
template. The receptor was optimized using the ‘Repair PDB’
function with sites Q39 and S76 fixed, as these side chains moved
considerably in the absence of ligand (which is not modeled in
FoldX). The ancestral state Cys71 was re-introduced into the
AncCR sequence, and the structure was energy-minimized. GR
substitutions were analyzed singly or in combination using the
‘Build Model’ function, and the change in protein stability
estimated as the average difference in the free energies between
the maximum likelihood and mutant AncCR structures (DDG) for
five runs. Several substitutions were excluded from the dataset
because they generated errors (‘‘segmentation fault’’ at sites Y27R,
Q213K, and K246Q), bordered gaps in the electron density of the
AncCR structure (A171V, K173R, and N175G), or contacted
ligand (A36G).
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